Syra Health Corp. Class A (SYRA)
OTHER OTC:SYRA
Want to see SYRA full AI Analyst Report?
SYRA Stock Chart & Stats
$0.09
-$0.12(-16.06%)
At close: 4:00 PM EST
$0.09
-$0.12(-16.06%)
Day’s Range― - ―
52-Week Range$0.05 - $0.70
Previous CloseN/A
Volume2.20M
Average Volume (3M)9.76K
Market Cap
$6.09M
Enterprise Value$3.39M
Total Cash (Recent Filing)$2.92M
Total Debt (Recent Filing)$73.09K
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding11,339,169
10 Day Avg. Volume11,249
30 Day Avg. Volume9,759
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.49
Price to Sales (P/S)0.14
P/FCF Ratio-2.28
Enterprise Value/Market Cap0.56
Enterprise Value/Revenue0.44
Enterprise Value/Gross Profit1.34
Enterprise Value/Ebitda-15.62
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Recovery & Margin ImprovementTrailing-twelve-month results show a material top-line rebound and much narrower losses, with gross margin near 33% and net margin improving to about -2.4%. This demonstrates operational leverage and progress toward profitability, supporting sustainable cash generation if execution continues.
Conservative LeverageVery low debt relative to equity (debt-to-equity ~0.03 TTM) meaningfully reduces financial risk and preserves flexibility. A conservative capital structure supports organic investment and cushioning against revenue volatility without forcing dilutive financing in the near term.
Improved Cash GenerationOperating and free cash flow turned positive in the TTM period, reflecting better alignment of earnings and cash. Sustained positive cash generation enhances self-funding capacity for growth initiatives, reduces reliance on external financing, and supports longer-term operational stability.
Bears Say
Profitability Still NegativeDespite improvement, ROE near -8% and lingering net losses indicate the company has not yet achieved consistent profitability. Persistent negative returns constrain reinvestment ability, limit retained-capital growth, and mean the firm remains sensitive to execution setbacks that could reverse progress.
Volatile Cash FlowsHistoric swings in operating and free cash flow reduce predictability for budgeting and strategic planning. Even with recent positive flows, volatility increases the likelihood of intermittent external funding needs and raises execution risk for multi-period investments or contract-backed growth initiatives.
Inconsistent Revenue SignalsConflicting indicators — large TTM growth cited elsewhere versus a negative reported revenue growth metric — suggest revenue may be lumpy or subject to timing/recognition effects. This inconsistency complicates forecasting and raises doubt about the durability of recent top-line improvement.
Syra Health Corp. Class A News
SYRA FAQ
What was Syra Health Corp. Class A’s price range in the past 12 months?
Syra Health Corp. Class A lowest stock price was $0.05 and its highest was $0.70 in the past 12 months.
What is Syra Health Corp. Class A’s market cap?
Syra Health Corp. Class A’s market cap is $6.09M.
When is Syra Health Corp. Class A’s upcoming earnings report date?
Syra Health Corp. Class A’s upcoming earnings report date is Aug 06, 2026 which is in 61 days.
How were Syra Health Corp. Class A’s earnings last quarter?
Syra Health Corp. Class A released its earnings results on May 07, 2026. The company reported $0.019 earnings per share for the quarter, beating the consensus estimate of N/A by $0.019.
Is Syra Health Corp. Class A overvalued?
According to Wall Street analysts Syra Health Corp. Class A’s price is currently Overvalued.
Does Syra Health Corp. Class A pay dividends?
Syra Health Corp. Class A does not currently pay dividends.
What is Syra Health Corp. Class A’s EPS estimate?
Syra Health Corp. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syra Health Corp. Class A have?
Syra Health Corp. Class A has 11,339,169 shares outstanding.
What happened to Syra Health Corp. Class A’s price movement after its last earnings report?
Syra Health Corp. Class A reported an EPS of $0.019 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 11.111%.
Which hedge fund is a major shareholder of Syra Health Corp. Class A?
Currently, no hedge funds are holding shares in SYRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Syra Health Corp. Class A
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.
Technical Analysis
American Shared Hospital Services
―
Concord Medical Services
―
―
Cryo-Cell International
―
P3 Health Partners
―
Ownership Overview
Options Prices
Currently, No data available
---